Product Information
HYDROMORPHONE HCL ER 12 MG TAB is a generic product labeled by Trigen Laboratories, LLC, priced at $10.4213 per EA under NDC 13811070210. Its NADAC has been published 282 times since Jan 11, 2017.
FDA first approved this application on Jul 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Hydromorphone Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12 mg/1
Manufacturer
Trigen Laboratories, LLCNDC
13811070210
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205629FDA Approved
7/7/2016
TE Code
AB
On Market Since
9/15/2016
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE HCL ER 12 MG TAB has been published 282 times since Jan 11, 2017, and over the history we have for it it has declined 24.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.4213 per EA |
|---|---|
| All-time high | $13.7450 (Apr 12, 2017) |
| All-time low | $6.6999 (Nov 20, 2024) |
| 52-week high | $10.5411 |
| 52-week low | $8.6407 |
| Median price | $9.3277 |
| Average price | $9.7471 |
| Largest weekly change | +26.4% (Nov 21, 2018) |
| Weeks tracked | 282 |
| Tracking since | Jan 11, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydromorphone Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Trigen Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydromorphone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROMORPHONE HCL ER 12 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 12 MG TAB, manufactured by Trigen Laboratories, LLC, is $10.4213 per EA (NDC 13811070210), effective Sep 30, 2026.
How has the price of HYDROMORPHONE HCL ER 12 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE HCL ER 12 MG TAB has declined 24.2%. It has been tracked across 282 weekly CMS publications since Jan 11, 2017.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 12 MG TAB?
Since Jan 11, 2017, the NADAC for HYDROMORPHONE HCL ER 12 MG TAB has ranged from a low of $6.6999 (Nov 20, 2024) to a high of $13.7450 (Apr 12, 2017), with a median of $9.3277 per EA.
Are there cheaper alternatives to HYDROMORPHONE HCL ER 12 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of HYDROMORPHONE HCL ER 12 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROMORPHONE HCL ER 12 MG TAB?
HYDROMORPHONE HCL ER 12 MG TAB (NDC 13811070210) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.